Alert detail
LCD L37903: MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer — CGS
What changed
CGS finalizes coverage for Inivata liquid biopsy in lung cancer (KY/OH).
Who’s affected: Oncology billing teams · Effective: June 19, 2025
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 7 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.